IMMUTEP LIMITED — Director's Dealing 2011

Jul 18, 2011

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

	PRIMA BIOMED LIMITED (ASX:PRR)
Name of Entity:
	90 009 237 889
ACN:

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director: Mr Richard Hammel Date of Last Notice: 10.12.2010

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest		Indirect	Indirect	Indirect	Indirect
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.		Director related entity Richard J Hammel International Business Consulting Inc
Date of change		1. 14 July 2011for exercise of $0.02 options 2. 18 July 2011 for disposal of fully paid ordinary shares
No. of securities held prior to change				Options - 12,619,047 12,619,047
			Shares	Options
		Direct	-	-
		Indirect	5,000,000	12,619,047
		**Total **	5,000,000	12,619,047
Class		Listed options and fully paid ordinary shares
Number acquired					Options - - -
			Shares		Options
		Direct	-		-
		Indirect	7,619,047		-
		Total	7,619,047		-

• See chapter 19 for defined terms.

Appendix 3Y Page 1

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

Number disposed				Options - 7,619,047 7,619,047
			Shares	Options
		Direct	-	-
		Indirect	2,416,560	7,619,047
		**Total **	2,416,560	7,619,047
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation		1. Options exercised price 0.02 per share 2. Shares disposed at an average price of $0.289
No. of securities held after change				Options - 5,000,000 5,000,000
			Shares	Options
		Direct	-	-
		Indirect	10,202,487	5,000,000
		**Total **	**10,202,487 **	5,000,000
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back		1. Acquiring 7,619,047 ordinary shares on the exercise of listed $0.02, 31/12/2011 options 2. Disposal of 2,416,560 ordinaryfully paid shares

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest
Name of registered holder (if issued securities)
Date of change
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed
Interest acquired
Interest disposed
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation
Interest after change

Part 3 - +Closed Period

Were the interests in the securities or contracts detailed above traded N/A during a +closed period where prior written clearance was required? If so, was prior written clearance provided to allow the trade to proceed during this period? If prior written clearance was provided on what date was this provided?

19.07.2011

• See chapter 19 for defined terms.

Appendix 3Y Page 2

11/3/2002